Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris
Abstract BACKGROUND: Psoriasis is a common, chronic, recurrent, immune-mediated disorder of the skin and joints. It can have a significant negative impact on the physical, emotional and psychosocial wellbeing of affected patients. OBJECTIVES: To measure improvement in health-related QoL (HRQoL) in G...
Saved in:
Main Authors: | George Kontochristopoulos (Author), Anargyros Kouris (Author), Athanasios Chantzaras (Author), Athanasios Petridis (Author), John Yfantopoulos (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
by: Efstratios Vakirlis, et al.
Published: (2008) -
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
by: Anderko M, et al.
Published: (2019) -
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
by: Pinter A, et al.
Published: (2018) -
New Calcipotriol/Betamethasone Dipropionate Foam Formulation for the Treatment of Psoriasis: An Overview
by: Tiago Torres, et al.
Published: (2018) -
Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
by: Colombo GL, et al.
Published: (2012)